# PARTNERSHIPS & COLLABORATION

**Strategic Alliances for Amplified Impact**

---

[← Previous: Risk Mitigation](./08_RISK_MITIGATION.md) | [Back to Index](./00_GRANT_PROPOSAL_INDEX.md) | [Next: Sustainability →](./10_SUSTAINABILITY_VISION.md)

**Status**: ✅ Complete
**Word Count**: ~4,000 words
**Last Updated**: November 9, 2025

---

## Executive Summary

**Uniting Doctors** cannot achieve its mission alone. Strategic partnerships multiply our impact by:

1. **Amplifying reach**: Partners connect us to millions of healthcare professionals
2. **Adding credibility**: Endorsements from trusted organizations build trust
3. **Enhancing content**: Partners provide expertise, resources, and validation
4. **Sharing infrastructure**: Leverage partners' existing systems and networks
5. **Co-creating solutions**: Collaborative innovation addresses shared challenges

This section outlines our partnership strategy across five categories:

- **Rare Disease Organizations**: Alpha-1 Foundation (founding partner) and 20+ additional patient advocacy groups
- **Medical Professional Societies**: AMA, specialty societies (50+ target partners)
- **Academic Institutions**: Medical schools, research universities (10+ partnerships)
- **Global Health Organizations**: WHO, MSF, Partners In Health (3-5 partnerships)
- **Technology & Data Partners**: PubMed/NLM, NIH, health data platforms

**Status**: 3 partnerships active or in negotiation, 20+ identified for outreach

---

## 1. Rare Disease Organizations

### 1.1 Alpha-1 Foundation (Founding Partner)

**Organization**: Leading nonprofit dedicated to Alpha-1 Antitrypsin Deficiency awareness, research, and patient support

**Why This Partnership Matters**:

- **Personal connection**: Founder's son has AATD (authentic partnership)
- **Aligned missions**: Both organizations aim to increase AATD diagnoses
- **Complementary strengths**: They have patient network, we have platform for professionals
- **Proof of concept**: AATD campaign demonstrates model for other rare diseases

---

**Partnership Activities**:

**Year 1**:

1. **Co-branded AATD Awareness Campaign**
   - 50+ clinical case discussions (anonymized AATD cases)
   - 10+ educational articles/videos (what is AATD? who to test?)
   - Expert AMAs with AATD specialists (monthly, first 6 months)
   - Social media campaign (#KnowAlpha1, joint promotion)

2. **Professional Education**
   - Target: 100,000+ healthcare professionals educated about AATD
   - Materials: Infographics, clinical guidelines, testing protocols
   - Distribution: Platform + Alpha-1 Foundation newsletter (50K reach)

3. **Data Sharing & Impact Tracking**
   - Track earlier diagnoses attributable to platform
   - Survey Alpha-1 Foundation network (testing rates before/after campaign)
   - Co-author research publication (intervention effectiveness)

4. **Cross-Promotion**
   - Feature Alpha-1 Foundation resources on platform (link to their website, patient support groups)
   - Feature Uniting Doctors in Alpha-1 Foundation communications (newsletter, conference materials)

**Year 2**: 5. **Patient Stories**

- Share patient perspectives (with consent) to humanize mission
- Video series: "Why Earlier Diagnosis Matters" (patient and family interviews)
- Connect diagnosed patients with platform community (thank healthcare professionals)

6. **Conference Collaboration**
   - Joint presentations at American Thoracic Society (ATS) conference
   - Co-branded booth at medical conferences
   - Physician-patient panels (bridge perspectives)

7. **Expanded Impact Measurement**
   - Partner with 5-10 institutions (track diagnostic rates)
   - Publish follow-up research (long-term impact)
   - Model for other rare diseases

---

**Formalization**:

- **Status**: Conversations initiated, MOU in progress
- **Timeline**: Sign MOU Month 1, launch campaign Month 3
- **Governance**: Quarterly check-ins (leadership), monthly coordination (staff)

**Mutual Benefits**:

- **Alpha-1 Foundation gains**: Massive reach to healthcare professionals (their key audience), platform for education, measurable impact
- **Uniting Doctors gains**: Credibility, content, network access, founding use case, patient perspective

---

### 1.2 Expanding to 20+ Rare Disease Organizations

**Model**: Replicate Alpha-1 approach with other rare disease patient advocacy groups

**Selection Criteria**:

1. Disease has diagnostic test (knowledge gap is main barrier, not lack of test)
2. Early diagnosis improves outcomes (matters for patients)
3. Active patient advocacy organization (partnership potential, infrastructure)
4. Prevalence: 1 in 2,000 to 1 in 50,000 (not ultra-rare, not common—sweet spot for awareness campaigns)

---

**Priority Partners** (Year 2-3):

1. **Hereditary Angioedema Association** (HAE)
   - HAE: rare, dangerous swelling attacks (can be fatal if airway)
   - Often misdiagnosed as allergic reactions for years
   - Simple blood test available

2. **National Fabry Disease Foundation**
   - Fabry: genetic disorder affecting kidneys, heart, nerves
   - Average diagnosis delay: 10+ years
   - Early enzyme replacement therapy prevents organ damage

3. **Immune Deficiency Foundation** (Primary Immunodeficiency)
   - Recurrent infections, often dismissed as "unlucky"
   - Many PIDs diagnosable with immunoglobulin levels
   - Early treatment prevents complications, improves quality of life

4. **The Ehlers-Danlos Society**
   - EDS: connective tissue disorder, often dismissed or misdiagnosed
   - Average diagnosis delay: 10-12 years
   - Growing awareness needed among physicians

5. **Wilson Disease Association**
   - Wilson disease: copper accumulation (liver, brain)
   - Treatable if diagnosed early
   - Often misdiagnosed as psychiatric disorder

6. **American Hemochromatosis Society**
   - Iron overload, damages organs
   - Simple blood test (ferritin, transferrin saturation)
   - Preventable organ damage with early diagnosis

7. **Marfan Foundation**
   - Marfan syndrome: connective tissue, affects heart/aorta
   - Life-threatening if undiagnosed (aortic dissection)
   - Clinical diagnosis, genetic testing available

8. **Myasthenia Gravis Foundation of America**
   - Autoimmune neuromuscular disorder
   - Muscle weakness, often misdiagnosed
   - Treatable with proper diagnosis

9. **Amyloidosis Foundation**
   - Protein deposits in organs (heart, kidneys)
   - Often misdiagnosed as heart failure
   - Earlier diagnosis critical

10. **National Organization for Rare Disorders (NORD)**
    - Umbrella organization (7,000+ rare diseases)
    - Partnership provides access to broader rare disease community
    - Potential co-funding for awareness campaigns

---

**Partnership Model** (for each):

**Phase 1** (Months 1-3): Relationship building

- Introductory meeting (explain platform, mutual benefits)
- MOU negotiation (formalize partnership)
- Joint planning (campaign strategy, timeline, responsibilities)

**Phase 2** (Months 4-9): Campaign launch

- Create dedicated community on platform (disease-specific)
- Educational content series (5-10 pieces)
- Expert AMAs (2-3 specialists)
- Social media campaign (joint promotion)

**Phase 3** (Months 10-18): Impact measurement

- Track diagnostic rates (patient advocacy org surveys their network)
- Document earlier diagnoses (case studies)
- Research publication (co-authored)

**Phase 4** (Ongoing): Sustain & scale

- Maintain community on platform
- Periodic campaigns (annual awareness month)
- Long-term partnership

---

**Resource Requirements**:

- **Year 1**: 1 partnership (Alpha-1 Foundation), 1.0 FTE (CMO + Community Manager)
- **Year 2**: Add 5 partnerships, 1.5 FTE (CMO + Community Manager + Partnerships Manager)
- **Year 3**: Add 10 partnerships, 2.0 FTE (grow team)

**Budget**: $50K-100K/year (content creation, staff time, travel for conferences)

---

**Target Impact** (across all rare disease partnerships by Year 3):

- 50+ rare disease communities active on platform
- 500,000+ professionals educated about rare diseases
- 10,000+ earlier rare disease diagnoses
- 25+ research publications (co-authored with patient advocacy partners)

---

## 2. Medical Professional Societies

### 2.1 American Medical Association (AMA)

**Organization**: Largest physician organization in US (271,000 members), sets standards for medical profession

**Why This Partnership Matters**:

- **Credibility**: AMA endorsement signals legitimacy to physicians
- **Reach**: 271,000 physician members (direct access)
- **Alignment**: AMA priorities include physician burnout, health equity, medical education

---

**Proposed Partnership**:

1. **AMA Member Benefit**
   - Offer free premium access to all AMA members (value-add to membership)
   - AMA promotes platform in newsletters, conferences
   - Co-branded landing page ("AMA Members: Join Uniting Doctors")

2. **Health Equity Collaboration**
   - AMA has health equity initiatives (address disparities)
   - Platform supports rural and underserved physicians (aligned mission)
   - Joint research on reducing healthcare disparities through knowledge sharing

3. **CME Partnership**
   - AMA offers CME credit
   - Platform provides CME-eligible content (with AMA accreditation)
   - Revenue share (platform pays AMA per CME credit, or vice versa)

4. **Conference Presence**
   - Exhibit at AMA annual conferences
   - Presentations (showcase platform, rare disease awareness)
   - Networking (recruit Medical Advisory Board members)

---

**Status**: Target for Year 1 outreach (Month 6+, after initial traction proven)

**Recruitment Strategy**:

- Identify AMA leadership connections (via Medical Advisory Board)
- Pitch to AMA Innovation team (they seek new physician tools)
- Offer pilot program (free for AMA leadership, gather feedback)

**Timeline**:

- **Month 6**: Initial outreach
- **Month 9**: Pilot with 50 AMA leaders
- **Month 12-18**: Negotiate formal partnership
- **Year 2**: Launch AMA member benefit

---

### 2.2 Specialty Medical Societies (50+ Target Partners)

**Why Specialty Societies?**:

- Physicians identify more with specialty than general "physician" identity
- Societies are trusted sources (members rely on them for education)
- Conferences are key networking/education venues

---

**Priority Specialty Societies** (Year 1-2):

**Tier 1** (Year 1 focus):

1. **American Thoracic Society (ATS)** - AATD focus aligns perfectly
2. **American College of Chest Physicians (ACCP)** - pulmonary, critical care
3. **American Academy of Family Physicians (AAFP)** - largest primary care society (134,000 members)
4. **American College of Physicians (ACP)** - internal medicine (161,000 members)
5. **Society of Hospital Medicine (SHM)** - hospitalists (20,000 members), often face unfamiliar cases

**Tier 2** (Year 2 expansion): 6. American Academy of Pediatrics (AAP) 7. American College of Emergency Physicians (ACEP) 8. American Society of Clinical Oncology (ASCO) 9. American Heart Association (AHA) 10. American Academy of Neurology (AAN) 11. American College of Cardiology (ACC) 12. American Psychiatric Association (APA) 13. American College of Obstetricians and Gynecologists (ACOG) 14. American Academy of Dermatology (AAD) 15. American Urological Association (AUA)

**And 35+ more** (cover all major specialties)

---

**Partnership Model** (for each society):

**Level 1**: Basic Partnership (Free)

- List platform in society's resource directory
- Mention platform in society newsletter (one-time or annual)
- Society logo on platform ("Supported by...")

**Level 2**: Content Partnership

- Society provides educational content (clinical guidelines, research summaries)
- Platform hosts society's content (with attribution)
- Co-branded specialty community (e.g., "Pulmonology Community - In Partnership with ATS")

**Level 3**: Institutional License

- Society purchases platform access for all members (institutional license)
- Revenue for platform ($10K-50K/year depending on size)
- Deep integration (single sign-on, co-branded)

**Level 4**: Strategic Partnership

- Joint research (publish on platform impact for specialty)
- Co-hosted events (webinars, conference sessions)
- Advisory relationship (society leaders advise platform strategy for specialty)

---

**Recruitment Strategy**:

**Phase 1**: Conference presence (attend 5-10 major conferences Year 1)

- ATS, AAFP, ACP, SHM, and others
- Exhibit booth ($2K-5K per conference)
- Presentations (submit abstracts showcasing platform)
- Networking (meet society leadership)

**Phase 2**: Direct outreach (via Medical Advisory Board connections)

- Identify physicians on our Advisory Board who are also society leaders
- Warm introductions (personal connection)
- Pilot programs (free access for society leadership, gather feedback)

**Phase 3**: Value demonstration

- Show early traction (25K users, 500 diagnoses, 5 publications)
- Demonstrate benefit to society members (user testimonials)
- Propose specific partnership terms

---

**Budget**: $50K-80K/year (conference exhibits, travel, partnership staff time)

**Timeline**:

- **Year 1**: 5 Tier 1 partnerships (basic or content level)
- **Year 2**: 15 additional partnerships (expand to Tier 2 societies)
- **Year 3**: 30+ partnerships (cover all major specialties)

---

### 2.3 Nursing & Allied Health Professional Societies

**Why These Partnerships?**:

- Nurses, PAs, pharmacists are 50%+ of platform users (not just physicians)
- Professional organizations for these roles are trusted sources
- Expand reach beyond physicians

**Priority Partners**:

1. **American Association of Nurse Practitioners (AANP)** - 123,000 members
2. **American Nurses Association (ANA)** - 4 million members
3. **American Academy of Physician Assistants (AAPA)** - 168,000 members
4. **American Pharmacists Association (APhA)** - 60,000 members
5. **American Physical Therapy Association (APTA)** - 100,000 members

**Partnership Model**: Same as physician societies (resource listing, content partnerships, institutional licenses)

---

## 3. Academic Institutions

### 3.1 Medical Schools & Residency Programs

**Why These Partnerships?**:

- Medical students and residents are future users (build loyalty early)
- Academic faculty are opinion leaders (influence broader physician community)
- Research opportunities (platform data for studies)

**Proposed Partnerships** (5-10 institutions):

**Tier 1 Targets** (Top medical schools):

1. Harvard Medical School
2. Johns Hopkins School of Medicine
3. Stanford School of Medicine
4. University of California, San Francisco (UCSF)
5. University of Pennsylvania (Penn Medicine)
6. Mayo Clinic Alix School of Medicine
7. Yale School of Medicine
8. Columbia Vagelos College of Physicians and Surgeons

**Tier 2 Targets** (Schools with global health focus): 9. Duke Global Health Institute 10. University of Washington School of Medicine 11. Emory School of Medicine 12. Boston University School of Medicine

---

**Partnership Activities**:

1. **Curriculum Integration**
   - Include platform in evidence-based medicine courses
   - Students/residents use platform for case discussions (with supervision)
   - Faculty model effective use (teach how to ask good questions, evaluate evidence)

2. **Research Collaboration**
   - Faculty study platform impact (knowledge translation, medical education effectiveness)
   - Platform data for research (with appropriate ethical oversight)
   - Co-authored publications (platform team + academic researchers)

3. **Institutional Licenses**
   - School purchases premium access for all students, residents, faculty
   - Revenue: $10K-25K/year per institution
   - Benefit: Enhanced training, faculty development

4. **Residency Program Integration**
   - Residents use platform during training (supervised case discussions)
   - Program directors track engagement (formative assessment)
   - Prepare residents for lifelong learning

5. **Faculty Participation**
   - Faculty join as expert contributors (answer questions, host AMAs)
   - Recognition (showcases expertise, attracts patients and students)
   - Professional development (teaching and leadership opportunities)

---

**Recruitment Strategy**:

**Phase 1** (Year 1): Pilot with 1-2 schools

- Target: Schools with Medical Advisory Board connections
- Free pilot year (demonstrate value)
- Gather feedback (what works? what needs improvement?)

**Phase 2** (Year 2): Expand to 5 schools

- Leverage pilot school testimonials
- Present at medical education conferences (AAMC, AMEE)
- Publish research on pilot outcomes

**Phase 3** (Year 3+): Scale to 20-50 schools

- Proven model, clear outcomes
- Institutional sales team (dedicated staff)
- Revenue stream (20 schools × $15K = $300K/year)

---

### 3.2 Research Universities & Global Health Programs

**Why These Partnerships?**:

- Academic validation (research publications enhance credibility)
- Global health expertise (help us expand internationally)
- Student/fellow involvement (low-cost, high-energy contributors)

**Target Institutions**:

1. Harvard T.H. Chan School of Public Health
2. Johns Hopkins Bloomberg School of Public Health
3. London School of Hygiene & Tropical Medicine
4. University of Washington Institute for Health Metrics and Evaluation (IHME)
5. Duke Global Health Institute

**Partnership Activities**:

- Joint research (global health knowledge translation)
- MPH student projects (capstone projects using platform data)
- Global health faculty on Medical Advisory Board
- Platform as field tool (support field workers in low-resource settings)

---

## 4. Global Health Organizations

### 4.1 Médecins Sans Frontières (Doctors Without Borders)

**Organization**: International humanitarian medical organization, 45,000+ staff in 70+ countries

**Why This Partnership Matters**:

- **Reach**: Field doctors in most resource-limited, isolated settings (exactly who we aim to serve)
- **Mission alignment**: Provide medical care where needed most (health equity)
- **Real-world impact**: Support frontline workers facing complex cases with limited resources
- **Reverse knowledge flow**: MSF field experiences can educate other healthcare professionals (lessons from humanitarian medicine)

---

**Proposed Partnership**:

1. **Free Premium Access for All MSF Field Staff**
   - 1,000+ physicians, nurses, and other healthcare professionals
   - No cost to MSF (mission-driven contribution)
   - Connect field doctors with specialists for complex case consultation

2. **Telemedicine Consultation Support**
   - Field doctor posts case question (anonymized)
   - Specialists worldwide respond within hours
   - Supplement (not replace) existing MSF medical support systems

3. **Mental Health & Peer Support**
   - MSF field work is emotionally taxing (trauma, resource limitations, burnout)
   - Platform provides peer community (other MSF workers, support each other)
   - Reduce isolation (connect field staff globally)

4. **Knowledge Sharing**
   - MSF field doctors share lessons learned (e.g., managing Ebola outbreak, improvised treatments in resource-limited settings)
   - Other healthcare professionals learn from MSF expertise
   - Bi-directional knowledge flow (not just "developed world helps developing world")

5. **Research Collaboration**
   - Document platform impact on field medicine
   - Co-author publications (humanitarian medicine, knowledge translation in crisis settings)

---

**Status**: Target for Year 2 outreach (after platform proven in North America)

**Timeline**:

- **Month 12-15**: Initial outreach (identify MSF leadership connections)
- **Month 18**: Pilot with 50 MSF field staff (gather feedback)
- **Month 24**: Formal partnership launch (all MSF staff)

**Budget**: $0 revenue (mission-driven), minimal cost (1,000 free premium accounts = $10K forgone revenue, but worth it)

---

### 4.2 World Health Organization (WHO)

**Organization**: United Nations agency for international public health

**Why This Partnership Matters**:

- **Global reach**: WHO works with ministries of health in 194 countries
- **Credibility**: WHO endorsement signals legitimacy globally
- **Pandemic preparedness**: Platform could serve as early warning system (unusual disease discussions)
- **Field worker support**: Connect WHO field staff with specialists

**Proposed Partnership** (exploratory):

1. **Pandemic Preparedness**
   - Monitor platform discussions for unusual disease patterns (e.g., novel symptoms, geographic clustering)
   - Early detection (before official reports)
   - Complement existing WHO surveillance systems

2. **Field Worker Support**
   - Free premium access for WHO field staff (similar to MSF model)
   - Connect with specialists for complex cases

3. **Global Health Education**
   - WHO educational materials featured on platform
   - Platform supports WHO campaigns (e.g., World Health Day)

4. **Research Collaboration**
   - Study platform as knowledge translation tool in LMICs
   - Publish findings in WHO Bulletin

---

**Status**: Aspirational (Year 2-3), requires significant vetting and relationship-building

---

### 4.3 Partners In Health (PIH)

**Organization**: Global health nonprofit, provides healthcare in 11 countries, focus on low-resource settings

**Partnership similar to MSF**: Free platform access, field worker support, knowledge sharing, research collaboration

---

## 5. Technology & Data Partners

### 5.1 National Library of Medicine (NLM) / PubMed

**Current Status**: PubMed API integration planned (see Methodology section)

**Potential Expanded Partnership**:

- Featured in NLM's list of recommended physician tools
- Collaboration on medical information literacy initiatives
- Research on how physicians use medical literature (platform data)

---

### 5.2 National Institutes of Health (NIH)

**Potential Partnership**:

- Platform as tool for NIH-funded researchers (disseminate findings to clinicians)
- Bridge research-to-practice gap (17-year lag)
- Funding opportunity (NIH grants for knowledge translation)

---

### 5.3 Open-Access Publishers (PLOS, BMJ Open, others)

**Partnership**:

- Seamlessly integrate open-access papers into platform
- Promote open-access publishing (align with our mission of knowledge accessibility)
- Publisher promotes platform to author network

---

## 6. Partnership Management

### 6.1 Governance

**Partnership Manager Role** (Scenario C, Year 2+):

- Dedicated staff member (full-time) to manage partnerships
- Responsibilities: Relationship management, contract negotiation, partnership performance tracking

**Partnership Advisory Committee**:

- Quarterly meetings (review partnership performance)
- Members: CEO, CMO, Partnerships Manager, 2 Board members
- Decisions: Which partnerships to prioritize, resource allocation

---

### 6.2 Partnership Performance Metrics

**For Each Partnership, Track**:

- Users acquired (via partner referral)
- Engagement (partner-referred users vs. organic users)
- Content contributions (partner-provided content usage)
- Revenue (if institutional license)
- Impact (diagnoses, publications, outcomes attributable to partnership)

**Quarterly Reviews**: Assess which partnerships delivering most value, adjust strategy

---

## Conclusion

**Partnerships are force multipliers.**

By partnering with rare disease organizations, medical societies, academic institutions, global health organizations, and technology providers, **Uniting Doctors** can:

- Reach millions of healthcare professionals (far more than we could alone)
- Build credibility (trusted organizations endorse us)
- Enhance content (partners provide expertise and resources)
- Amplify impact (collaborative innovation)

**We are not building a platform alone—we are building a movement with partners.**

---

[← Previous: Risk Mitigation](./08_RISK_MITIGATION.md) | [Back to Index](./00_GRANT_PROPOSAL_INDEX.md) | [Next: Sustainability →](./10_SUSTAINABILITY_VISION.md)

**Questions about partnerships?**
grants@unitingdoctors.org
